Cargando…

Clinical Equivalence of Polyglycolic Acid Suture and Polyglactin 910 Suture for Subcutaneous Tissue Closure After Cesarean Delivery: A Single-Blind Randomized Study

PURPOSE: The global rise in frequency of cesarean delivery raises the concern to minimize the post-operative complications, in order to improve the maternal and neonatal health. Closure of subcutaneous tissue following cesarean section closes dead space, hence reduces the wound complications. No pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Devi, C H R Vasundara, Ray, Rathindranath, Koduri, Sindhu, Moharana, Ashok Kumar, TS, Deepak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893844/
https://www.ncbi.nlm.nih.gov/pubmed/36741332
http://dx.doi.org/10.2147/MDER.S385988
_version_ 1784881611650629632
author Devi, C H R Vasundara
Ray, Rathindranath
Koduri, Sindhu
Moharana, Ashok Kumar
TS, Deepak
author_facet Devi, C H R Vasundara
Ray, Rathindranath
Koduri, Sindhu
Moharana, Ashok Kumar
TS, Deepak
author_sort Devi, C H R Vasundara
collection PubMed
description PURPOSE: The global rise in frequency of cesarean delivery raises the concern to minimize the post-operative complications, in order to improve the maternal and neonatal health. Closure of subcutaneous tissue following cesarean section closes dead space, hence reduces the wound complications. No previous study has compared the clinical equivalence of polyglycolic acid suture with polyglactin 910 suture for subcutaneous tissue closure following cesarean section. Therefore, this study compared the incidence of subcutaneous abdominal wound disruptions within the first 6 weeks of subcutaneous tissue closure with either of the sutures. PATIENTS AND METHODS: A single-blind, prospective, randomized study was conducted in two centres between February and November, 2021. Primiparous or multiparous women (18–40 years) with a singleton pregnancy requiring cesarean section were randomized to polyglycolic acid suture (Truglyde(®)) (n=54) and polyglactin 910 suture (Vicryl(®)) (n=54) group. The primary endpoint, incidence of subcutaneous abdominal wound disruptions within 6 weeks of cesarean delivery was evaluated. In addition, the secondary endpoints, incidence of post-operative subcutaneous abdominal wound disruptions for the study period, skin disruption, surgical site infection (SSI), seroma, hematoma, intraoperative handling, operative time, hospital stay, suture removal, microbial deposits on sutures, pain, time taken to resume normal activities, and adverse events were recorded. RESULTS: Non-significant difference in the incidence of subcutaneous abdominal wound disruptions, skin disruption, SSI, seroma, hematoma, intraoperative handling characteristics, operative time, pain, duration of hospital stay, suture removal, microbial deposits, time taken to return to day-to-day activities, and adverse events were observed between the two treatment groups. CONCLUSION: Following cesarean section, subcutaneous tissue closure using polyglycolic acid suture or polyglactin 910 suture was not associated with incidence of subcutaneous abdominal wound disruptions. Additionally, non-significant differences regarding secondary endpoints between the groups suggested the clinical equivalence of the sutures. CTRI REGISTRATION NUMBER: CTRI/2020/12/029737; Registration date: 11/12/2020.
format Online
Article
Text
id pubmed-9893844
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-98938442023-02-03 Clinical Equivalence of Polyglycolic Acid Suture and Polyglactin 910 Suture for Subcutaneous Tissue Closure After Cesarean Delivery: A Single-Blind Randomized Study Devi, C H R Vasundara Ray, Rathindranath Koduri, Sindhu Moharana, Ashok Kumar TS, Deepak Med Devices (Auckl) Original Research PURPOSE: The global rise in frequency of cesarean delivery raises the concern to minimize the post-operative complications, in order to improve the maternal and neonatal health. Closure of subcutaneous tissue following cesarean section closes dead space, hence reduces the wound complications. No previous study has compared the clinical equivalence of polyglycolic acid suture with polyglactin 910 suture for subcutaneous tissue closure following cesarean section. Therefore, this study compared the incidence of subcutaneous abdominal wound disruptions within the first 6 weeks of subcutaneous tissue closure with either of the sutures. PATIENTS AND METHODS: A single-blind, prospective, randomized study was conducted in two centres between February and November, 2021. Primiparous or multiparous women (18–40 years) with a singleton pregnancy requiring cesarean section were randomized to polyglycolic acid suture (Truglyde(®)) (n=54) and polyglactin 910 suture (Vicryl(®)) (n=54) group. The primary endpoint, incidence of subcutaneous abdominal wound disruptions within 6 weeks of cesarean delivery was evaluated. In addition, the secondary endpoints, incidence of post-operative subcutaneous abdominal wound disruptions for the study period, skin disruption, surgical site infection (SSI), seroma, hematoma, intraoperative handling, operative time, hospital stay, suture removal, microbial deposits on sutures, pain, time taken to resume normal activities, and adverse events were recorded. RESULTS: Non-significant difference in the incidence of subcutaneous abdominal wound disruptions, skin disruption, SSI, seroma, hematoma, intraoperative handling characteristics, operative time, pain, duration of hospital stay, suture removal, microbial deposits, time taken to return to day-to-day activities, and adverse events were observed between the two treatment groups. CONCLUSION: Following cesarean section, subcutaneous tissue closure using polyglycolic acid suture or polyglactin 910 suture was not associated with incidence of subcutaneous abdominal wound disruptions. Additionally, non-significant differences regarding secondary endpoints between the groups suggested the clinical equivalence of the sutures. CTRI REGISTRATION NUMBER: CTRI/2020/12/029737; Registration date: 11/12/2020. Dove 2023-01-29 /pmc/articles/PMC9893844/ /pubmed/36741332 http://dx.doi.org/10.2147/MDER.S385988 Text en © 2023 Devi et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Devi, C H R Vasundara
Ray, Rathindranath
Koduri, Sindhu
Moharana, Ashok Kumar
TS, Deepak
Clinical Equivalence of Polyglycolic Acid Suture and Polyglactin 910 Suture for Subcutaneous Tissue Closure After Cesarean Delivery: A Single-Blind Randomized Study
title Clinical Equivalence of Polyglycolic Acid Suture and Polyglactin 910 Suture for Subcutaneous Tissue Closure After Cesarean Delivery: A Single-Blind Randomized Study
title_full Clinical Equivalence of Polyglycolic Acid Suture and Polyglactin 910 Suture for Subcutaneous Tissue Closure After Cesarean Delivery: A Single-Blind Randomized Study
title_fullStr Clinical Equivalence of Polyglycolic Acid Suture and Polyglactin 910 Suture for Subcutaneous Tissue Closure After Cesarean Delivery: A Single-Blind Randomized Study
title_full_unstemmed Clinical Equivalence of Polyglycolic Acid Suture and Polyglactin 910 Suture for Subcutaneous Tissue Closure After Cesarean Delivery: A Single-Blind Randomized Study
title_short Clinical Equivalence of Polyglycolic Acid Suture and Polyglactin 910 Suture for Subcutaneous Tissue Closure After Cesarean Delivery: A Single-Blind Randomized Study
title_sort clinical equivalence of polyglycolic acid suture and polyglactin 910 suture for subcutaneous tissue closure after cesarean delivery: a single-blind randomized study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893844/
https://www.ncbi.nlm.nih.gov/pubmed/36741332
http://dx.doi.org/10.2147/MDER.S385988
work_keys_str_mv AT devichrvasundara clinicalequivalenceofpolyglycolicacidsutureandpolyglactin910sutureforsubcutaneoustissueclosureaftercesareandeliveryasingleblindrandomizedstudy
AT rayrathindranath clinicalequivalenceofpolyglycolicacidsutureandpolyglactin910sutureforsubcutaneoustissueclosureaftercesareandeliveryasingleblindrandomizedstudy
AT kodurisindhu clinicalequivalenceofpolyglycolicacidsutureandpolyglactin910sutureforsubcutaneoustissueclosureaftercesareandeliveryasingleblindrandomizedstudy
AT moharanaashokkumar clinicalequivalenceofpolyglycolicacidsutureandpolyglactin910sutureforsubcutaneoustissueclosureaftercesareandeliveryasingleblindrandomizedstudy
AT tsdeepak clinicalequivalenceofpolyglycolicacidsutureandpolyglactin910sutureforsubcutaneoustissueclosureaftercesareandeliveryasingleblindrandomizedstudy